ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,854Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 1006

$955K Total Retail Price of All Prescriptions

Rank: 44 out of 1006

546 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 546 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 546 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 13,411 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 1,188 1,051 1 2
SIMVASTATIN 485 444 2 1
LISINOPRIL 467 452 3 3
METOPROLOL TARTRATE 455 445 4 7
WARFARIN SODIUM 426 382 5 8
PRAVASTATIN SODIUM 425 381 6 15
FUROSEMIDE 356 330 7 6
AMLODIPINE BESYLATE 339 335 8 4
AZITHROMYCIN 303 257 9 39
OMEPRAZOLE 245 216 10 9
LOVASTATIN 243 237 11 44
CITALOPRAM HBR 223 192 12 24
DONEPEZIL HCL 207 182 13 17
METOPROLOL SUCCINATE 203 199 14 12
ZETIA 191 173 15 51
PREDNISONE 184 164 16 33
GABAPENTIN 182 158 17 20
NAMENDA 181 181 18 34
ZOLPIDEM TARTRATE 175 169 19 14
SPIRONOLACTONE 174 167 20 71
ATORVASTATIN CALCIUM 173 148 21 5
CRESTOR 161 129 22 18
ATENOLOL 160 160 23 13
DIOVAN 158 157 24 16
HYDROCHLOROTHIAZIDE 151 132 25 11
LOSARTAN POTASSIUM 148 141 26 22
SERTRALINE HCL 143 136 27 19
NEXIUM 134 131 28 28
METFORMIN HCL 131 125 29 10
CLOPIDOGREL 125 120 30 46
LIDODERM 123 119 31 66
MIRTAZAPINE 123 123 31 26
ESCITALOPRAM OXALATE 123 110 31 27
FENTANYL 121 99 S2 34 74
HYDROCODONE-ACETAMINOPHEN 117 105 S3 35 25
ISOSORBIDE MONONITRATE ER 117 117 35 59
CYMBALTA 111 92 37 41
TRAZODONE HCL 111 98 37 21
TAMSULOSIN HCL 109 107 39 23
PANTOPRAZOLE SODIUM 87 81 40 32
DIVALPROEX SODIUM 85 51 41 53
POLYETHYLENE GLYCOL 3350 84 84 42 91
PLAVIX 84 84 42 61
NITROGLYCERIN PATCH 83 83 44 160
VYTORIN 82 67 45 145
DIGOXIN 81 81 46 52
SULFAMETHOXAZOLE-TRIMETHOPRIM 80 71 47 118
OLANZAPINE 79 70 48 68
DOXAZOSIN MESYLATE 77 62 49 87
TRAMADOL HCL 75 55 50 35
SYNTHROID 75 69 50 42
TRIAMTERENE-HCTZ 72 72 52 58
ADVAIR DISKUS 70 65 53 37
EXELON 67 67 54 99
CARVEDILOL 64 63 55 36
TRIAMCINOLONE ACETONIDE 60 49 56 135
BENICAR 59 55 57 78
LANSOPRAZOLE 56 46 58 141
RISPERIDONE 54 52 59 40
ACETIC ACID 53 0 60 372
POTASSIUM CHLORIDE 52 48 61 30
FAMOTIDINE 51 38 62 110
NITROFURANTOIN MONO-MACRO 51 49 62 180
ALLOPURINOL 50 34 64 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 3, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.